Masimo

Jury Rules in Favor of Apple, Awards $250 Million in Smartwatch Patent Dispute Against Masimo

by

In a significant legal victory, Apple Inc. has been awarded a $250 million jury verdict against Masimo Corp., a medical technology company that had accused the tech giant of infringing on its patents related to smartwatch technology. The decision was reached in Wilmington, Delaware, marking a crucial moment in the ongoing disputes over technology and intellectual property rights in the burgeoning field of wearable devices. The jury found that Apple did not infringe on Masimo’s patents, a decision that underscores the intense competition and high stakes in the market for health-focused technology products. Masimo had … Read more

Jury Sides Mostly with Masimo in Heated Apple Smartwatch Patent Battle, Minor Damages Awarded

by

Wilmington, Delaware – In a recent legal battle over intellectual property, Apple Inc. made a strong case against fellow tech company Masimo, claiming that Masimo’s earlier models of smartwatches, specifically the W1 and Freedom watches along with their chargers, violated Apple’s design patents. Following deliberations, a federal jury sided with Apple, determining that these specific products had indeed infringed upon Apple’s patented smartwatch designs. The impact of the infringement, according to the jury, was minimal, leading to a nominal award of just $250 in damages to Apple. This amount represents the statutory minimum for patent … Read more

Masimo Seeks Bench Trial in Renewed Intellectual Property Battle with Apple Over Smartwatch Technology

by

Irvine, CA—In a renewed effort to rectify what it considers a misuse of proprietary technology, Masimo, the Irvine-based medical technology firm, is pushing for a bench trial in its intellectual property lawsuit against tech giant Apple. This legal move comes after a jury was unable to reach a verdict last year over allegations that Apple’s smartwatches improperly used Masimo’s technology designed to monitor blood oxygen levels. Masimo argues that its trade secrets, critical to its innovative blood oxygen monitoring systems, were unfairly utilized in Apple’s popular smartwatches. The impasse during the previous jury trial has … Read more